Showing results (651-660 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|September 24, 2015
Comparative effectiveness of tenofovir in treatment-naïve HIV-infected patients: systematic review and meta-analysisLars G Hemkens, Hannah Ewald, Marilia Santini-Oliveira, et al.
HIV Clinical Trials|January 19, 2016
Serum amyloid P (SAP) is associated with impaired brachial artery flow-mediated dilation in chronically HIV-1 infected adults on stable antiretroviral therapyNath Zungsontiporn, Lishomwa C Ndhlovu, Brooks I Mitchell, et al.
HIV Clinical Trials|October 29, 2014
Week 144 resistance analysis of elvitegravir/cobicistat/emtricitabine/tenofovir DF versus atazanavir+ritonavir+emtricitabine/tenofovir DF in antiretroviral-naïve patientsRima Kulkarni, Michael E Abram, Damian J McColl, et al.
HIV Clinical Trials|August 23, 2017
Soluble TWEAK may predict carotid atherosclerosis in treated HIV infectionSahera Dirajlal-Fargo, Abdus Sattar, Manjusha Kulkarni, et al.
HIV Clinical Trials|February 1, 2018
False-positive HIV diagnoses: lessons from Ugandan and Russian research cohortsSharon M Coleman, Natalia Gnatienko, Christine A Lloyd-Travaglini, et al.
HIV Clinical Trials|March 18, 2015
Reliability and validity of a single-item rating scale to monitor medication adherence for people living with HIV and lower health literacyJennifer A Pellowski, Seth C Kalichman, David J Finitsis
HIV Clinical Trials|March 18, 2015
The maraviroc expanded access program - safety and efficacy data from an open-label studyAdriano Lazzarin, Jacques Reynes, Jean-Michel Molina, et al.
HIV Clinical Trials|August 2, 2012
Renal toxicity associated with antiretroviral therapyLeonardo Calza
HIV Clinical Trials|August 2, 2012
Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients: week-192 overall and subgroup analyses from STARTMRKEdwin DeJesus, Jürgen K Rockstroh, Jeffrey L Lennox, et al.
HIV Clinical Trials|April 16, 2015
Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safetyTaisheng Li, Jing Xie, Yijia Li, et al.
Pageof 68